SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-092913
Filing Date
2024-10-31
Accepted
2024-10-31 16:28:52
Documents
14
Period of Report
2024-10-26
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0219516-8k_klotho.htm   iXBRL 8-K 31243
  Complete submission text file 0001213900-24-092913.txt   249846

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE klto-20241026.xsd EX-101.SCH 3497
3 XBRL DEFINITION FILE klto-20241026_def.xml EX-101.DEF 26516
4 XBRL LABEL FILE klto-20241026_lab.xml EX-101.LAB 36424
5 XBRL PRESENTATION FILE klto-20241026_pre.xml EX-101.PRE 25140
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0219516-8k_klotho_htm.xml XML 5482
Mailing Address 1115 BROADWAY 12TH FLOOR NEW YORK NY 10010
Business Address 1115 BROADWAY 12TH FLOOR NEW YORK NY 10010 646-916-5315
Klotho Neurosciences, Inc. (Filer) CIK: 0001907223 (see all company filings)

IRS No.: 862727441 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41340 | Film No.: 241415640
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)